Capital Guardian Trust’s DexCom DXCM Stock Holding History

Capital Guardian Trust’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-320	Closed	-$5K	–	703
2016 Q1	$5K	Buy	+320	New	+$5.35K	﹤0.01%	676

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Guardian Trust's DXCM Position: Q2 2016 in Review

Capital Guardian Trust sold out of DexCom (DXCM) in Q2 2016, closing a stake of 320 shares — an estimated $5K sold.

Capital Guardian Trust first reported a position in DXCM in Q1 2016 and held it in 1 quarter. The position peaked at $5K in Q1 2016. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2016.

Capital Guardian Trust reported no remaining DexCom position as of Q2 2016 after selling out during the quarter.
Capital Guardian Trust sold 320 DexCom shares in Q2 2016, an estimated $5K.
Capital Guardian Trust first reported a position in DexCom in Q1 2016 and held it in 1 quarter.
Capital Guardian Trust's DexCom position peaked at $5K in Q1 2016.
279 funds tracked by Wall St. Rank held DexCom as of Q2 2016.

Based on Capital Guardian Trust's 13F filing for Q2 2016, filed 15 Aug 2016.